OR.PA : Summary for L''OREAL - Yahoo Finance

U.S. Markets open in 5 hrs 31 mins

L'Oréal S.A. (OR.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
169.50-0.05 (-0.03%)
As of 9:44AM CET. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close169.55
Bid167.00 x 6000
Ask169.85 x 35000
Day's Range169.25 - 170.00
52 Week Range144.15 - 177.90
Avg. Volume556,914
Market Cap94.9B
PE Ratio (TTM)33.10
Earnings DateN/A
Dividend & Yield3.57 (1.96%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters9 days ago

    Valeant to sell assets for $2.12 billion to ease debt load

    Valeant's U.S.-listed shares (VRX.N) rose as much as 14 percent on Tuesday, before paring gains to 5.7 percent at $16.22 in afternoon trading. Laval, Quebec-based Valeant has been the subject of recent investigations by congressional panels as well as the Federal Trade Commission and the U.S. Securities and Exchange Commission. French cosmetics group L'Oreal (OREP.PA) is buying CeraVe, AcneFree and Ambi from Valeant for about $1.3 billion in cash.

  • Benzinga9 days ago

    Valeant's Asset Sale To L'Oreal Explained

    Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) announced an agreement to sell its CeraVe, AcneFree and AMBI Skincare brands to L'Oreal SA (ADR) (OTC: LRLCY ) for $1.3 billion. According to Gadfly's Andrea ...

  • TheStreet.com9 days ago

    L'Oreal Buys Skincare Lines From Valeant for $1.3 Billion -- and Jim Cramer's Comments

    L'Oreal just wrote a huge check to Valeant.